Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Automated cancer detection using mri
June 22, 2017 - N°20170176565

Methods and systems for diagnosing cancer in the prostate and other organs are disclosed. Exemplary methods comprises extracting texture information from mri imaging data for a target organ, sometimes using two or more different imaging modalities. Texture features are determined that are indicative of cancer by identifying frequent texture patterns. A classification model is generated based on the determined texture ...
NEW Method for detecting or monitoring prostate cancer
Oncosense Inc. (usa)
June 22, 2017 - N°20170176443

The present invention provides methods identifying subjects having prostate cancer (pca) by detecting in microparticles a pair of biomarkers. The methods disclosed can be used to distinguish subjects having pca from those having non-malignant prostate pathologies, including benign prostatic hyperplasia. Methods for monitoring prostate cancer and assessing efficacy of prostate cancer therapies are also disclosed. Kits for detecting prostate cancer ...
NEW Protein biomarker profiles for detecting colorectal tumors
Applied Proteomics, Inc.
June 22, 2017 - N°20170176441

Disclosed herein are panels related to the diagnosis or recognition of colon and colorectal cancer in a subject. The disclosed panels and related methods are used to predict or assess colon tumor status in a patient. They can be used to determine nature of tumor, recurrence, or patient response to treatments. Some embodiments of the methods include generating a report ...
NEW Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Method of diagnosing and monitoring bladder cancer and melanoma
The Board Of Regents Of The University Of Texas System
June 22, 2017 - N°20170176437

The present invention provides a method for the diagnosing and monitoring of melanoma
NEW Methods (amacr)
University Of Bath
June 22, 2017 - N°20170176436

A method of measuring α-methylacyl-coa racemase (amacr) activity in a sample is described comprising the steps of: (i) providing a sample; (ii) contacting said sample with a substrate compound that undergoes elimination of hydrogen and a leaving group catalysed by said amacr to produce a product compound having an additional carbon-carbon double bond; and (iii) measuring the amount ...
NEW Electrochemical method and device for detecting the effect of anticancer drugs
University Of Bath
June 22, 2017 - N°20170176414

An electrochemical method for detecting effect of an anticancer drug on cancer cells, including: culturing a plurality of cancer cells to form cultured cells, attaching the cultured cells onto an array of silicon nanowires (sinws) electrodes, measuring a first electrochemical response of the attached cells onto the array of electrodes, adding an anticancer drug to the attached cells onto the ...
NEW Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Distinguishing methylation levels in complex biological samples
Illumina, Inc.
June 22, 2017 - N°20170175205

Provided herein is a method for distinguishing an aberrant methylation level for dna from a first cell type, including steps of (a) providing a test data set that includes (i) methylation states for a plurality of sites from test genomic dna from at least one test organism, and (ii) coverage at each of the sites for detection of the methylation ...
NEW Methods and devices for predicting anthracycline treatment efficacy
Ontario Institute For Cancer Research
June 22, 2017 - N°20170175204

The invention features methods, devices, and kits for predicting the responsiveness of a cancer patient (e. G., a breast cancer patient, such as a grade 1, 2, or 3 breast cancer patient) to anthracycline treatment by determining the expression levels of four chromosomal instability (cin) genes including hdgf, kiaa0286, rfc4, and msh6, collectively referred to as cin4. Patients that have a low cin4 ...
NEW Evaluation method for evaluating the likelihood of breast cancer
Sistemas GenÓmicos, S.l.
June 22, 2017 - N°20170175203

The invention relates to a method for evaluating the likelihood of a person having breast cancer, the method including detecting and quantifying specific micrornas in serum or plasma, the expression of which is related to the presence of a breast tumour. The invention also relates to the use of specific micrornas, the expression of which is related to the presence ...
NEW The tgf(beta)-mir200-mig6 pathway and its use in the treatment of cancer as ...
The Johns Hopkins University
June 22, 2017 - N°20170175201

The present invention provides methods for identifying the susceptibility of a cancer cell or population of cells to treatment with epidermal growth factor (egf) tyrosine kinase inhibitors (tkis), such as erlotinib. Methods for the in vitro diagnosis of the susceptibility of a tumor in a subject to treatment with tkis and monitoring tumor susceptibility during treatment are also provided.
NEW Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
Sloan-kettering Institute For Cancer Research
June 22, 2017 - N°20170175200

The present invention is directed to methods of prognosing, treating, or managing treatment of cancer in a subject. These methods involve selecting a subject having cancer, obtaining, from the selected subject, a sample containing exosomes, recovering the exosomes from the sample, and isolating the double-stranded dna from within the exosomes. The isolated double-stranded dna is then used to detect the ...
NEW Immune gene signatures in urothelial carcinoma (uc)
H. Lee Moffitt Cancer Center And Research Institute, Inc.
June 22, 2017 - N°20170175199

This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
NEW Retroviral vector having immune-stimulating activity
Tocagen Inc.
June 22, 2017 - N°20170175137

The disclosure provides vectors for treating cancers, method of producing such vectors and methods of use of the vectors.
NEW Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
Thomas Jefferson University
June 22, 2017 - N°20170175123

Microrna genes are highly associated with chromosomal features involved in the etiology of different cancers. The perturbations in the genomic structure or chromosomal architecture of a cell caused by these cancer-associated chromosomal features can affect the expression of the mir gene(s) located in close proximity to that chromosomal feature. Evaluation of mir gene expression can therefore be used to ...
NEW Composition and method of using mir-302 precursors as anti-cancer drugs for treating human lung cancer
Thomas Jefferson University
June 22, 2017 - N°20170175118

This invention generally relates to a composition and method of using mam-made small rnas, such as small interfering rnas (sirna), micrornas (mirna) and their hairpin-like precursors (pre-mirna), as tumor suppressing anti-cancer drugs for treating human tumors and cancers, in particular, but not limited, for treating skin (melanoma), blood (leukemia), prostate, breast, liver and lung cancers as well as various neoplastic ...
NEW Use of anti-pd-1 antibody in combination with anti-cd27 antibody in cancer treatment
Celldex Therapeutics, Inc
June 22, 2017 - N°20170174774

This invention provides methods for treating cancer in a subject comprising administering to the subject an anti-pd-1 antibody and an anti-cd27 antibody. In some embodiments, the cancer is colorectal cancer, rectal cancer, colon cancer, lung cancer, melanoma, ovarian cancer, head and neck cancer, or any combination thereof.
NEW Combination of a pd-1 antagonist and a 4-1bb agonist for treating cancer
Merck Sharp & Dohme Corp.
June 22, 2017 - N°20170174773

The present disclosure describes combination therapies comprising an antagonist of programmed death 1 receptor (pd-1) and a selective 4-1 bb agonist, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express pd-l1.
NEW Monoclonal antibodies to progastrin and their uses
Centre National De La Recherche Scientifique (cnrs)
June 22, 2017 - N°20170174761

The present disclosure is directed to progastrin monoclonal antibodies, fragments thereof, compositions comprising progastrin monoclonal antibodies, and methods of making and using progastrin monoclonal antibodies and compositions thereof. The present disclosure is directed to methods of treating colorectal cancer with progastrin monoclonal antibodies and compositions comprising progastrin monoclonal antibodies or fragments thereof. The present disclosure is further directed to methods ...
NEW Method for treating breast cancer
Alethia Biotherapeutics Inc.
June 22, 2017 - N°20170174753

Breast cancer cells lacking er protein expression, pgr protein expression and/or showing absence of her2 protein over-expression (i. E., triple-negative breast cancer cells, basal-like) can be efficiently targeted with an anti-kaag1 antibody and killed upon delivery of a therapeutic moiety. Antibodies and antigen binding fragments that specifically binds to kaag1 may thus be used for the, detection and therapeutic ...
NEW Mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- ...
The Johns Hopkins University
June 22, 2017 - N°20170174749

Mimetic peptides having anti-angiogenic and anti-tumorigenic properties and methods of their use for treating cancer, ocular diseases, such as age-related macular degeneration, and other-angiogenesis-dependent diseases are disclosed. More particularly, active non-cysteine analogs (mimetics), which exhibit anti-angiogenic activity in endothelial cell proliferation, migration, adhesion, and tube formation assays, anti-migratory activity in human breast cancer cells in vitro, anti-angiogenic and anti-tumorigenic activity ...
NEW Modification of cupredoxin derived peptides and methods of use thereof
The Board Of Trustees Of The University Of Illinois
June 22, 2017 - N°20170174729

The present invention provides modified cupredoxin derived peptides with pharmacologic activity that have improved pharmacokinetic properties, and methods to use them to treat mammals suffering from various conditions related to the pharmacologic activities. Modifications of the cupredoxin derived peptides include amino acid sequence variants and structural derivations that increase the plasma half-life of the peptide, increase the specific activity of ...
Loading